Structure

Physi-Chem Properties

Molecular Weight:  262.12
Volume:  266.942
LogP:  1.078
LogD:  0.941
LogS:  -3.111
# Rotatable Bonds:  2
TPSA:  55.9
# H-Bond Aceptor:  4
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.432
Synthetic Accessibility Score:  4.981
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.709
MDCK Permeability:  1.4320091395347845e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.028

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.081
Plasma Protein Binding (PPB):  61.039405822753906%
Volume Distribution (VD):  1.204
Pgp-substrate:  48.76415252685547%

ADMET: Metabolism

CYP1A2-inhibitor:  0.297
CYP1A2-substrate:  0.203
CYP2C19-inhibitor:  0.081
CYP2C19-substrate:  0.506
CYP2C9-inhibitor:  0.139
CYP2C9-substrate:  0.116
CYP2D6-inhibitor:  0.036
CYP2D6-substrate:  0.195
CYP3A4-inhibitor:  0.13
CYP3A4-substrate:  0.31

ADMET: Excretion

Clearance (CL):  6.406
Half-life (T1/2):  0.775

ADMET: Toxicity

hERG Blockers:  0.174
Human Hepatotoxicity (H-HT):  0.96
Drug-inuced Liver Injury (DILI):  0.767
AMES Toxicity:  0.164
Rat Oral Acute Toxicity:  0.276
Maximum Recommended Daily Dose:  0.913
Skin Sensitization:  0.923
Carcinogencity:  0.595
Eye Corrosion:  0.954
Eye Irritation:  0.953
Respiratory Toxicity:  0.976

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC62815

Natural Product ID:  NPC62815
Common Name*:   8-Epixanthatin-1Beta,5Beta-Epoxide
IUPAC Name:   (1aR,2S,3aR,6aR,7aR)-2-methyl-6-methylidene-1a-[(E)-3-oxobut-1-enyl]-2,3,3a,6a,7,7a-hexahydrooxireno[6,7]cyclohepta[1,2-b]furan-5-one
Synonyms:  
Standard InCHIKey:  NGAVJIMZMAIVPV-ODTBHIJQSA-N
Standard InCHI:  InChI=1S/C15H18O4/c1-8-6-12-11(10(3)14(17)18-12)7-13-15(8,19-13)5-4-9(2)16/h4-5,8,11-13H,3,6-7H2,1-2H3/b5-4+/t8-,11+,12+,13+,15-/m0/s1
SMILES:  C[C@H]1C[C@@H]2[C@H](C[C@@H]3[C@@]1(/C=C/C(=O)C)O3)C(=C)C(=O)O2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2380789
PubChem CID:   14633043
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001543] Sesquiterpene lactones
            • [CHEMONTID:0000502] Xanthanolides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32861 xanthium brasilicum Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[23501116]
NPO8815 Artemisia myriantha Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[32842729]
NPO8815 Artemisia myriantha Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8815 Artemisia myriantha Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8815 Artemisia myriantha Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT659 Cell Line SMMC-7721 Homo sapiens IC50 > 10000.0 nM PMID[456533]
NPT1229 Cell Line Huh-7 Homo sapiens IC50 = 8200.0 nM PMID[456533]
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10000.0 nM PMID[456533]
NPT840 Individual Protein Transcriptional activator Myb Gallus gallus IC50 = 13212.96 nM PMID[456532]
NPT27 Others Unspecified IC50 > 30000.0 nM PMID[456532]
NPT840 Individual Protein Transcriptional activator Myb Gallus gallus IC50 = 13220.0 nM PMID[456532]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC62815 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8977 High Similarity NPC166919
0.8966 High Similarity NPC475703
0.8966 High Similarity NPC231889
0.8941 High Similarity NPC272814
0.8889 High Similarity NPC135776
0.8876 High Similarity NPC312042
0.8778 High Similarity NPC20713
0.875 High Similarity NPC474741
0.8736 High Similarity NPC474547
0.8721 High Similarity NPC39588
0.8696 High Similarity NPC474947
0.8667 High Similarity NPC329857
0.8667 High Similarity NPC469718
0.8667 High Similarity NPC475748
0.8636 High Similarity NPC50637
0.8636 High Similarity NPC470242
0.8587 High Similarity NPC476267
0.8587 High Similarity NPC140543
0.8587 High Similarity NPC473316
0.8587 High Similarity NPC473330
0.8556 High Similarity NPC151770
0.8556 High Similarity NPC4986
0.8556 High Similarity NPC32922
0.8523 High Similarity NPC161957
0.8495 Intermediate Similarity NPC304886
0.8488 Intermediate Similarity NPC141810
0.8462 Intermediate Similarity NPC49342
0.8462 Intermediate Similarity NPC251385
0.8454 Intermediate Similarity NPC475945
0.8454 Intermediate Similarity NPC475871
0.8438 Intermediate Similarity NPC474742
0.8427 Intermediate Similarity NPC64153
0.8427 Intermediate Similarity NPC284902
0.8421 Intermediate Similarity NPC208233
0.8404 Intermediate Similarity NPC476275
0.8387 Intermediate Similarity NPC477131
0.8387 Intermediate Similarity NPC474035
0.8387 Intermediate Similarity NPC81386
0.837 Intermediate Similarity NPC284185
0.837 Intermediate Similarity NPC74103
0.837 Intermediate Similarity NPC150978
0.837 Intermediate Similarity NPC70595
0.837 Intermediate Similarity NPC123177
0.8351 Intermediate Similarity NPC474747
0.8333 Intermediate Similarity NPC270270
0.8333 Intermediate Similarity NPC118601
0.8315 Intermediate Similarity NPC319795
0.8315 Intermediate Similarity NPC215364
0.8315 Intermediate Similarity NPC38468
0.8315 Intermediate Similarity NPC50362
0.8298 Intermediate Similarity NPC14961
0.8298 Intermediate Similarity NPC270013
0.8295 Intermediate Similarity NPC170377
0.8295 Intermediate Similarity NPC318468
0.8283 Intermediate Similarity NPC223450
0.8283 Intermediate Similarity NPC243998
0.828 Intermediate Similarity NPC228451
0.828 Intermediate Similarity NPC212486
0.828 Intermediate Similarity NPC125674
0.828 Intermediate Similarity NPC475838
0.8276 Intermediate Similarity NPC301477
0.8276 Intermediate Similarity NPC25684
0.8276 Intermediate Similarity NPC281949
0.8261 Intermediate Similarity NPC144133
0.8261 Intermediate Similarity NPC179394
0.8261 Intermediate Similarity NPC51004
0.8261 Intermediate Similarity NPC253144
0.8256 Intermediate Similarity NPC617
0.8242 Intermediate Similarity NPC224652
0.8242 Intermediate Similarity NPC202672
0.8242 Intermediate Similarity NPC178875
0.8235 Intermediate Similarity NPC65603
0.8229 Intermediate Similarity NPC473326
0.8222 Intermediate Similarity NPC474045
0.8222 Intermediate Similarity NPC107787
0.8222 Intermediate Similarity NPC469676
0.8222 Intermediate Similarity NPC261253
0.8211 Intermediate Similarity NPC35498
0.8211 Intermediate Similarity NPC476315
0.8202 Intermediate Similarity NPC472957
0.8202 Intermediate Similarity NPC138647
0.8202 Intermediate Similarity NPC472958
0.8202 Intermediate Similarity NPC470238
0.8191 Intermediate Similarity NPC470013
0.8191 Intermediate Similarity NPC470010
0.8191 Intermediate Similarity NPC471147
0.8191 Intermediate Similarity NPC323008
0.8191 Intermediate Similarity NPC474247
0.8191 Intermediate Similarity NPC303942
0.8191 Intermediate Similarity NPC262133
0.8191 Intermediate Similarity NPC57405
0.8182 Intermediate Similarity NPC203659
0.8172 Intermediate Similarity NPC261607
0.8172 Intermediate Similarity NPC221282
0.8172 Intermediate Similarity NPC133698
0.8172 Intermediate Similarity NPC111114
0.8172 Intermediate Similarity NPC300312
0.8172 Intermediate Similarity NPC131209
0.8172 Intermediate Similarity NPC30515
0.8161 Intermediate Similarity NPC474510
0.8161 Intermediate Similarity NPC74673
0.8161 Intermediate Similarity NPC69271
0.8152 Intermediate Similarity NPC295312
0.8152 Intermediate Similarity NPC307411
0.8152 Intermediate Similarity NPC78008
0.8144 Intermediate Similarity NPC288876
0.8132 Intermediate Similarity NPC160138
0.8111 Intermediate Similarity NPC21471
0.8111 Intermediate Similarity NPC78089
0.8111 Intermediate Similarity NPC33570
0.8111 Intermediate Similarity NPC235792
0.8105 Intermediate Similarity NPC275960
0.8105 Intermediate Similarity NPC475659
0.8105 Intermediate Similarity NPC48803
0.8105 Intermediate Similarity NPC90121
0.8105 Intermediate Similarity NPC193645
0.809 Intermediate Similarity NPC250315
0.809 Intermediate Similarity NPC53867
0.809 Intermediate Similarity NPC474472
0.809 Intermediate Similarity NPC257358
0.8085 Intermediate Similarity NPC475912
0.8085 Intermediate Similarity NPC81419
0.8085 Intermediate Similarity NPC476300
0.8085 Intermediate Similarity NPC179746
0.8081 Intermediate Similarity NPC110989
0.8081 Intermediate Similarity NPC475873
0.8068 Intermediate Similarity NPC35089
0.8068 Intermediate Similarity NPC47635
0.8068 Intermediate Similarity NPC10276
0.8065 Intermediate Similarity NPC475855
0.8061 Intermediate Similarity NPC476270
0.8061 Intermediate Similarity NPC264477
0.8061 Intermediate Similarity NPC477511
0.8046 Intermediate Similarity NPC63649
0.8046 Intermediate Similarity NPC264227
0.8046 Intermediate Similarity NPC472965
0.8043 Intermediate Similarity NPC91248
0.8043 Intermediate Similarity NPC475902
0.8041 Intermediate Similarity NPC221615
0.8041 Intermediate Similarity NPC141191
0.8041 Intermediate Similarity NPC279561
0.8041 Intermediate Similarity NPC54843
0.8023 Intermediate Similarity NPC476794
0.8023 Intermediate Similarity NPC470240
0.8022 Intermediate Similarity NPC122502
0.8021 Intermediate Similarity NPC473859
0.8021 Intermediate Similarity NPC279621
0.8021 Intermediate Similarity NPC230800
0.8021 Intermediate Similarity NPC17585
0.8 Intermediate Similarity NPC115786
0.8 Intermediate Similarity NPC226669
0.8 Intermediate Similarity NPC193351
0.8 Intermediate Similarity NPC167219
0.8 Intermediate Similarity NPC471143
0.8 Intermediate Similarity NPC138408
0.8 Intermediate Similarity NPC477510
0.8 Intermediate Similarity NPC198853
0.798 Intermediate Similarity NPC149371
0.798 Intermediate Similarity NPC225353
0.7979 Intermediate Similarity NPC184463
0.7979 Intermediate Similarity NPC12172
0.7979 Intermediate Similarity NPC208886
0.7978 Intermediate Similarity NPC246076
0.7978 Intermediate Similarity NPC173609
0.7959 Intermediate Similarity NPC477512
0.7957 Intermediate Similarity NPC268298
0.7957 Intermediate Similarity NPC472872
0.7955 Intermediate Similarity NPC276356
0.7955 Intermediate Similarity NPC223904
0.7955 Intermediate Similarity NPC302426
0.7938 Intermediate Similarity NPC213947
0.7938 Intermediate Similarity NPC170143
0.7938 Intermediate Similarity NPC108475
0.7938 Intermediate Similarity NPC169205
0.7935 Intermediate Similarity NPC5130
0.7931 Intermediate Similarity NPC128276
0.7931 Intermediate Similarity NPC472960
0.7921 Intermediate Similarity NPC54737
0.7917 Intermediate Similarity NPC52044
0.7917 Intermediate Similarity NPC36954
0.7917 Intermediate Similarity NPC476053
0.7917 Intermediate Similarity NPC471141
0.7917 Intermediate Similarity NPC67584
0.7917 Intermediate Similarity NPC107476
0.7912 Intermediate Similarity NPC197903
0.7912 Intermediate Similarity NPC165162
0.7912 Intermediate Similarity NPC99395
0.7907 Intermediate Similarity NPC235906
0.7895 Intermediate Similarity NPC153590
0.7889 Intermediate Similarity NPC170286
0.7889 Intermediate Similarity NPC54468
0.7889 Intermediate Similarity NPC475842
0.7882 Intermediate Similarity NPC476355
0.7879 Intermediate Similarity NPC47880
0.7879 Intermediate Similarity NPC171759
0.7879 Intermediate Similarity NPC201718
0.7879 Intermediate Similarity NPC474339
0.7879 Intermediate Similarity NPC164598
0.7872 Intermediate Similarity NPC71533
0.7872 Intermediate Similarity NPC301969

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC62815 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8556 High Similarity NPD1695 Approved
0.8315 Intermediate Similarity NPD1733 Clinical (unspecified phase)
0.8105 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD1694 Approved
0.75 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD6371 Approved
0.732 Intermediate Similarity NPD46 Approved
0.732 Intermediate Similarity NPD6698 Approved
0.7238 Intermediate Similarity NPD6008 Approved
0.7143 Intermediate Similarity NPD7838 Discovery
0.7021 Intermediate Similarity NPD5209 Approved
0.7021 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.697 Remote Similarity NPD5785 Approved
0.6941 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6931 Remote Similarity NPD5282 Discontinued
0.6847 Remote Similarity NPD6053 Discontinued
0.6804 Remote Similarity NPD5363 Approved
0.6762 Remote Similarity NPD6648 Approved
0.6735 Remote Similarity NPD5786 Approved
0.6733 Remote Similarity NPD7983 Approved
0.6698 Remote Similarity NPD5344 Discontinued
0.6667 Remote Similarity NPD6435 Approved
0.6667 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5779 Approved
0.6667 Remote Similarity NPD5778 Approved
0.6566 Remote Similarity NPD4249 Approved
0.6562 Remote Similarity NPD5369 Approved
0.6545 Remote Similarity NPD5954 Clinical (unspecified phase)
0.65 Remote Similarity NPD4251 Approved
0.65 Remote Similarity NPD4250 Approved
0.6495 Remote Similarity NPD4270 Approved
0.6495 Remote Similarity NPD4269 Approved
0.6486 Remote Similarity NPD6686 Approved
0.6466 Remote Similarity NPD7115 Discovery
0.646 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6458 Remote Similarity NPD5368 Approved
0.6429 Remote Similarity NPD5362 Discontinued
0.6429 Remote Similarity NPD7154 Phase 3
0.6372 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6355 Remote Similarity NPD4225 Approved
0.6355 Remote Similarity NPD7638 Approved
0.6337 Remote Similarity NPD3573 Approved
0.63 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6296 Remote Similarity NPD7639 Approved
0.6296 Remote Similarity NPD7640 Approved
0.6289 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6289 Remote Similarity NPD4819 Approved
0.6289 Remote Similarity NPD4821 Approved
0.6289 Remote Similarity NPD4252 Approved
0.6289 Remote Similarity NPD4822 Approved
0.6289 Remote Similarity NPD4820 Approved
0.6283 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6281 Remote Similarity NPD7642 Approved
0.6277 Remote Similarity NPD8039 Approved
0.625 Remote Similarity NPD8513 Phase 3
0.625 Remote Similarity NPD8516 Approved
0.625 Remote Similarity NPD8515 Approved
0.625 Remote Similarity NPD8517 Approved
0.625 Remote Similarity NPD5693 Phase 1
0.625 Remote Similarity NPD5697 Approved
0.625 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6238 Remote Similarity NPD6684 Approved
0.6238 Remote Similarity NPD7334 Approved
0.6238 Remote Similarity NPD7521 Approved
0.6238 Remote Similarity NPD7146 Approved
0.6238 Remote Similarity NPD6409 Approved
0.6238 Remote Similarity NPD5330 Approved
0.6226 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6214 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6214 Remote Similarity NPD6101 Approved
0.6207 Remote Similarity NPD4632 Approved
0.6195 Remote Similarity NPD6881 Approved
0.6195 Remote Similarity NPD6899 Approved
0.6195 Remote Similarity NPD6011 Approved
0.619 Remote Similarity NPD7260 Phase 2
0.619 Remote Similarity NPD6399 Phase 3
0.6174 Remote Similarity NPD6650 Approved
0.6174 Remote Similarity NPD6649 Approved
0.6168 Remote Similarity NPD7839 Suspended
0.6154 Remote Similarity NPD5207 Approved
0.614 Remote Similarity NPD6014 Approved
0.614 Remote Similarity NPD6013 Approved
0.614 Remote Similarity NPD6012 Approved
0.6132 Remote Similarity NPD7900 Approved
0.6132 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6117 Remote Similarity NPD6672 Approved
0.6117 Remote Similarity NPD6903 Approved
0.6117 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6117 Remote Similarity NPD5737 Approved
0.6095 Remote Similarity NPD6411 Approved
0.6087 Remote Similarity NPD7102 Approved
0.6087 Remote Similarity NPD6883 Approved
0.6087 Remote Similarity NPD7290 Approved
0.6082 Remote Similarity NPD4271 Approved
0.6082 Remote Similarity NPD4268 Approved
0.605 Remote Similarity NPD6009 Approved
0.6034 Remote Similarity NPD6847 Approved
0.6034 Remote Similarity NPD6617 Approved
0.6034 Remote Similarity NPD8130 Phase 1
0.6034 Remote Similarity NPD6869 Approved
0.6033 Remote Similarity NPD6319 Approved
0.6018 Remote Similarity NPD5739 Approved
0.6018 Remote Similarity NPD6675 Approved
0.6018 Remote Similarity NPD7128 Approved
0.6018 Remote Similarity NPD6402 Approved
0.6016 Remote Similarity NPD7604 Phase 2
0.6016 Remote Similarity NPD7830 Approved
0.6016 Remote Similarity NPD7829 Approved
0.6 Remote Similarity NPD6372 Approved
0.6 Remote Similarity NPD8074 Phase 3
0.6 Remote Similarity NPD6373 Approved
0.5984 Remote Similarity NPD5983 Phase 2
0.5983 Remote Similarity NPD6882 Approved
0.5983 Remote Similarity NPD8297 Approved
0.5981 Remote Similarity NPD6001 Approved
0.5968 Remote Similarity NPD7492 Approved
0.5965 Remote Similarity NPD5701 Approved
0.5963 Remote Similarity NPD7902 Approved
0.5954 Remote Similarity NPD7966 Clinical (unspecified phase)
0.5943 Remote Similarity NPD5284 Approved
0.5943 Remote Similarity NPD5694 Approved
0.5943 Remote Similarity NPD5281 Approved
0.5941 Remote Similarity NPD5331 Approved
0.5941 Remote Similarity NPD5332 Approved
0.5934 Remote Similarity NPD7331 Phase 2
0.5926 Remote Similarity NPD5695 Phase 3
0.592 Remote Similarity NPD7507 Approved
0.592 Remote Similarity NPD6616 Approved
0.592 Remote Similarity NPD8273 Phase 1
0.5913 Remote Similarity NPD5345 Clinical (unspecified phase)
0.5913 Remote Similarity NPD7320 Approved
0.5909 Remote Similarity NPD5696 Approved
0.5905 Remote Similarity NPD6673 Approved
0.5905 Remote Similarity NPD6080 Approved
0.5905 Remote Similarity NPD6904 Approved
0.5902 Remote Similarity NPD6054 Approved
0.59 Remote Similarity NPD4790 Discontinued
0.5897 Remote Similarity NPD2181 Clinical (unspecified phase)
0.5893 Remote Similarity NPD5211 Phase 2
0.5891 Remote Similarity NPD6845 Suspended
0.5873 Remote Similarity NPD7078 Approved
0.5868 Remote Similarity NPD7641 Discontinued
0.5856 Remote Similarity NPD5285 Approved
0.5856 Remote Similarity NPD5286 Approved
0.5856 Remote Similarity NPD4696 Approved
0.5854 Remote Similarity NPD6016 Approved
0.5854 Remote Similarity NPD6015 Approved
0.5854 Remote Similarity NPD6291 Clinical (unspecified phase)
0.5849 Remote Similarity NPD5692 Phase 3
0.5842 Remote Similarity NPD4800 Clinical (unspecified phase)
0.5833 Remote Similarity NPD7748 Approved
0.5827 Remote Similarity NPD7736 Approved
0.5824 Remote Similarity NPD7341 Phase 2
0.5818 Remote Similarity NPD6084 Phase 2
0.5818 Remote Similarity NPD6083 Phase 2
0.5816 Remote Similarity NPD4756 Discovery
0.5812 Remote Similarity NPD2067 Discontinued
0.581 Remote Similarity NPD5208 Approved
0.5806 Remote Similarity NPD6370 Approved
0.5806 Remote Similarity NPD5988 Approved
0.5804 Remote Similarity NPD5223 Approved
0.5794 Remote Similarity NPD6050 Approved
0.5794 Remote Similarity NPD6336 Discontinued
0.5794 Remote Similarity NPD7637 Suspended
0.5794 Remote Similarity NPD6079 Approved
0.5789 Remote Similarity NPD5141 Approved
0.5785 Remote Similarity NPD6317 Approved
0.5784 Remote Similarity NPD6110 Phase 1
0.5781 Remote Similarity NPD7319 Approved
0.5769 Remote Similarity NPD6422 Discontinued
0.5763 Remote Similarity NPD6401 Clinical (unspecified phase)
0.5755 Remote Similarity NPD5370 Suspended
0.5755 Remote Similarity NPD6051 Approved
0.5752 Remote Similarity NPD5226 Approved
0.5752 Remote Similarity NPD4633 Approved
0.5752 Remote Similarity NPD5224 Approved
0.5752 Remote Similarity NPD5225 Approved
0.5752 Remote Similarity NPD7632 Discontinued
0.5738 Remote Similarity NPD6313 Approved
0.5738 Remote Similarity NPD6335 Approved
0.5738 Remote Similarity NPD6314 Approved
0.5727 Remote Similarity NPD5221 Approved
0.5727 Remote Similarity NPD5222 Approved
0.5727 Remote Similarity NPD5220 Clinical (unspecified phase)
0.5702 Remote Similarity NPD6274 Approved
0.5702 Remote Similarity NPD5175 Approved
0.5702 Remote Similarity NPD5174 Approved
0.5699 Remote Similarity NPD4247 Clinical (unspecified phase)
0.5691 Remote Similarity NPD7100 Approved
0.5691 Remote Similarity NPD7101 Approved
0.569 Remote Similarity NPD6412 Phase 2
0.5678 Remote Similarity NPD4634 Approved
0.5676 Remote Similarity NPD5173 Approved
0.5676 Remote Similarity NPD4755 Approved
0.5673 Remote Similarity NPD1696 Phase 3
0.5669 Remote Similarity NPD8451 Approved
0.5656 Remote Similarity NPD7500 Approved
0.5648 Remote Similarity NPD4810 Clinical (unspecified phase)
0.5648 Remote Similarity NPD7515 Phase 2
0.5645 Remote Similarity NPD6059 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data